| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,785 |
9,938 |
$751K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,181 |
8,366 |
$451K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,155 |
673 |
$98K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,640 |
1,616 |
$52K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,002 |
2,958 |
$31K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
300 |
297 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
6,323 |
5,770 |
$20K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,240 |
1,190 |
$16K |
| 97803 |
|
389 |
374 |
$14K |
| X5622 |
|
1,029 |
1,006 |
$14K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
163 |
163 |
$13K |
| 90686 |
|
1,931 |
1,871 |
$12K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
145 |
145 |
$10K |
| 92551 |
|
1,280 |
1,262 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
286 |
283 |
$7K |
| 80061 |
Lipid panel |
410 |
392 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
71 |
70 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
471 |
456 |
$4K |
| 99215 |
Prolong outpt/office vis |
25 |
25 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
165 |
159 |
$2K |
| 85027 |
|
428 |
409 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
228 |
219 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
41 |
39 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
166 |
160 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
193 |
176 |
$1K |
| 0064A |
|
35 |
34 |
$1K |
| 80053 |
Comprehensive metabolic panel |
138 |
138 |
$1K |
| 99188 |
|
187 |
186 |
$1K |
| 97802 |
|
14 |
12 |
$1K |
| 99173 |
|
1,167 |
1,154 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$794.96 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
66 |
66 |
$374.35 |
| 96127 |
|
102 |
101 |
$308.68 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
13 |
$260.68 |
| 90656 |
|
28 |
28 |
$252.02 |
| 99177 |
|
12 |
12 |
$17.36 |
| 87081 |
|
56 |
53 |
$8.76 |
| 90633 |
|
14 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
30 |
30 |
$0.00 |
| 90651 |
|
12 |
12 |
$0.00 |